Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis

International Archives of Allergy and Immunology

Volumn 151, Issue 2, 2010, Pages 129-136

  Fukushima, Atsuki ^a   Ishida, Waka ^a   Ojima, Ayako ^a   Kajisako, Mina ^a   Sumi, Tamaki ^a   Yamada, Jun ^b   Tsuru, Emi ^c   Miyazaki, Jun Ichi ^d   Tominaga, Akira ^c   Yagita, Hideo ^e  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b MEIJI UNIVERSITY OF INTEGRATIVE MEDICINE   (Japan)

^c KOCHI UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e JUNTENDO UNIVERSITY   (Japan)

Author keywords

Allergic conjunctivitis; CD11b; Eosinophil; F4 80; Mouse

Indexed keywords

CD11B ANTIGEN; EOTAXIN; F4 80 ANTIGEN; INTERLEUKIN 5; MEMBRANE ANTIGEN; UNCLASSIFIED DRUG;

ALLERGIC CONJUNCTIVITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; EOSINOPHIL COUNT; EOSINOPHILIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAGWEED POLLEN; SPLEEN CELL; UPREGULATION;

AMBROSIA; ANIMALS; ANTIBODIES; ANTIBODIES, MONOCLONAL; ANTIGENS, CD11B; ANTIGENS, DIFFERENTIATION; CELL COUNT; CELL MOVEMENT; CHEMOKINE CCL11; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; EOSINOPHIL MAJOR BASIC PROTEIN; EOSINOPHILIA; EOSINOPHILS; FEMALE; GENE TRANSFER TECHNIQUES; INTERFERON-GAMMA; INTERLEUKIN-5; INTERLEUKINS; MALE; MICE; MICE, INBRED BALB C; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SPLEEN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION;

EID: 70049114808     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000236002     Document Type: Article

References (19)

1. Fukagawa K, Nakajima T, Tsubota K, Shimmura S, Saito H, Hirai K: Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. J Allergy Clin Immunol 1999; 103: 1220-1221.
2. Messmer EM, May CA, Stefani FH, Welge- Luessen U, Kampik A: Toxic eosinophil granule protein deposition in corneal ulcerations and scars associated with atopic keratoconjunctivitis. Am J Ophthalmol 2002; 134: 816-821.
3. Yoshida O, Yoshida H, Iwamoto H, Nishino K, Fukushima A, Ueno H: Genetic background determines the nature of immune responses and experimental immune-mediated blepharoconjunctivitis (EC). Curr Eye Res 1999; 18: 117-124.
4. Fukushima A, Ozaki A, Jian Z, Ishida W, Fukata K, Ueno H, Liu FT: Dissection of antigen- specific humoral and cellular immune responses for the development of experimental immune-mediated blepharoconjunctivitis in C57BL/6 mice. Curr Eye Res 2005; 30: 241-248.
5. Fukushima A, Ozaki A, Fukata K, Ishida W, Ueno H: Ag-specific recognition, activation, and effector function of T cells in the conjunctiva with experimental immune-mediated blepharoconjunctivitis. Invest Ophthalmol Vis Sci 2003; 44: 4366-4374.
6. Ozaki A, Seki Y, Fukushima A, Kubo M: The control of allergic conjunctivitis by suppressor of cytokine signaling (SOCS)3 and SOCS5 in a murine model. J Immunol 2005; 175: 5489-5497.
7. Ozaki A, Fukushima A, Ishida W, Zinchuk O, Fukata K, Hayashi Y, Enzan H, Takata M, Yagita H, Ueno H: Analysis of Ag-presenting cells in the conjunctiva during the development of experimental immune-mediated blepharoconjunctivitis. Curr Eye Res 2004; 29: 277-286. (Pubitemid 40095011)
8. Remold-O'Donnell E: Regulation of synthesis of macrophage adhesion molecule, a heterodimeric membrane glycoprotein. J Immunol 1988; 140: 1244-1249.
9. Hirsch S, Austyn JM, Gordon S: Expression of the macrophage-specific antigen F4/80 during differentiation of mouse bone marrow cells in culture. J Exp Med 1981; 154: 713-725.
10. Aihara H, Miyazaki J: Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16: 867-870.
11. Watanabe Y, Hashizume M, Kataoka S, Hamaguchi E, Morimoto N, Tsuru S, Katoh S, Miyake K, Matsushima K, Tominaga M, Kurashige T, Fujimoto S, Kincade PW, Tominaga A: Differentiation stages of eosinophils characterized by hyaluronic acid binding via CD44 and responsiveness to stimuli. DNA Cell Biol 2001; 20: 189-202.
12. Watanabe Y, Hamaguchi-Tsuru E, Morimoto N, Nishio Y, Yagyu K, Konishi Y, Tominaga M, Miyazaki J, Furuya M, Tominaga A: IL-5-induced eosinophils suppress the growth of Leishmania amazonensis in vivo and kill Promastigotes in vitro in response to either IL-4 or IFN-gamma. DNA Cell Biol 2004; 23: 412-418.
13. Fukushima A, Yamaguchi T, Azuma M, Yagita H, Ueno H: Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice. Br J Ophthalmol 2006; 90: 1040-1045.
14. Hartnell A, Moqbel R, Walsh GM, Bradley B, Kay AB: Fc gamma and CD11/CD18 receptor expression on normal density and low density human eosinophils. Immunology 1990; 69: 264-270.
15. Thorne KJ, Richardson BA, Mazza G, Butterworth AE: A new method for measuring eosinophil activating factors, based on the increased expression of CR3 alpha chain (CD11b) on the surface of activated eosinophils. J Immunol Methods 1990; 133: 47-54.
16. McGarry MP, Stewart CC: Murine eosinophil granulocytes bind the murine macrophage- monocyte specific monoclonal antibody F4/80. J Leukoc Biol 1991; 50: 471-478.
17. Ahrens R, Waddell A, Seidu L, Blanchard C, Carey R, Forbes E, Lampinen M, Wilson T, Cohen E, Stringer K, Ballard E, Munitz A, Xu H, Lee N, Lee JJ, Rothenberg ME, Denson L, Hogan SP: Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis. J Immunol 2008; 181: 7390-7399.
18. Kanwar S, Smith CW, Shardonofsky FR, Burns AR: The role of Mac-1 (CD11b/CD18) in antigen-induced airway eosinophilia in mice. Am J Respir Cell Mol Biol 2001; 25: 170-177.
19. Fukushima A, Yamaguchi T, Ishida W, Fukata K, Ueno H: Role of VLA-4 in the development of allergic conjunctivitis in mice. Mol Vis 2006; 12: 310-317.